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Oxidized phospholipids—Their properties and interactions with proteinsLipids are a highly diverse class of biomolecules, with an average
eukaryotic cell estimated as containing at least 100,000 different
species. The signiﬁcance of this diversity is still poorly understood,
yet it has become clear that lipids have critical regulatory as well as
structural roles, varying from signaling (e.g. phosphatidylinositols,
prostaglandins, platelet activating factor, ceramide) to the control of
permeability properties of skin, for instance.
An unprecedented discovery from recent efforts in lipidomics,
aimed at the elucidation of the functional roles of lipids in cells, was
the key role for lipid oxidation in cell behavior and pathology. More
speciﬁcally, oxidized phospholipids (oxPL) have been shown to in-
crease signiﬁcantly in apoptosis as well as in inﬂammation and to
be involved in several pathological conditions, such as atherosclero-
sis, cancer, inﬂammation, Alzheimer's and Parkinson's disease, as
well as type 2 diabetes, with the detailed mechanisms remaining to
be established. However, a coherent overall view of the causalities
and mechanisms has been lacking, mainly because of insufﬁcient un-
derstanding of the cellular as well as molecular level mechanisms.
This Special Issue represents a focused, integrated interdisciplinary
approach summarizing very recent leading edge developments in
this emerging ﬁeld with emphasis on lipid–protein interactions. The
data now becoming available are paving the way to the development
of improved diagnostics, therapies and preventive measures to com-
bat the above diseases.0005-2736/$ – see front ma
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